ArticleJournal of cardiothoracic surgery2025

Comparison of efficacy and safety in two versus three cycles of neoadjuvant immunotherapy plus chemotherapy for esophageal squamous cell carcinoma.

Guanzhi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.